Bard Associates’s Viemed Healthcare VMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.32M | Sell |
336,328
-13,295
| -4% | -$91.9K | 0.75% | 47 |
|
2025
Q1 | $2.55M | Buy |
349,623
+97
| +0% | +$706 | 0.95% | 37 |
|
2024
Q4 | $2.8M | Buy |
349,526
+4,474
| +1% | +$35.9K | 0.95% | 34 |
|
2024
Q3 | $2.53M | Buy |
345,052
+3,762
| +1% | +$27.6K | 0.86% | 42 |
|
2024
Q2 | $2.24M | Sell |
341,290
-925
| -0.3% | -$6.06K | 0.86% | 42 |
|
2024
Q1 | $3.23M | Buy |
342,215
+3,880
| +1% | +$36.6K | 1.16% | 24 |
|
2023
Q4 | $2.66M | Buy |
338,335
+303,880
| +882% | +$2.39M | 1.01% | 33 |
|
2023
Q3 | $232K | Buy |
34,455
+10,530
| +44% | +$70.9K | 0.1% | 150 |
|
2023
Q2 | $234K | Sell |
23,925
-68
| -0.3% | -$665 | 0.09% | 151 |
|
2023
Q1 | $232K | Buy |
23,993
+1,000
| +4% | +$9.66K | 0.1% | 156 |
|
2022
Q4 | $174K | Buy |
22,993
+2,000
| +10% | +$15.1K | 0.07% | 165 |
|
2022
Q3 | $126K | Buy |
20,993
+100
| +0.5% | +$600 | 0.06% | 165 |
|
2022
Q2 | $112K | Buy |
20,893
+3,000
| +17% | +$16.1K | 0.05% | 170 |
|
2022
Q1 | $89K | Buy |
17,893
+168
| +0.9% | +$836 | 0.03% | 178 |
|
2021
Q4 | $93K | Hold |
17,725
| – | – | 0.03% | 174 |
|
2021
Q3 | $98K | Buy |
17,725
+2,000
| +13% | +$11.1K | 0.03% | 168 |
|
2021
Q2 | $112K | Buy |
+15,725
| New | +$112K | 0.04% | 167 |
|